- Report
- April 2025
- 450 Pages
Global
From €3507EUR$3,995USD£3,009GBP
- Report
- May 2025
- 188 Pages
Global
From €3112EUR$3,545USD£2,670GBP
€3458EUR$3,939USD£2,967GBP
- Report
- February 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,382GBP
- Report
- November 2024
- 150 Pages
Global
From €2853EUR$3,250USD£2,448GBP
€4257EUR$4,850USD£3,653GBP
- Report
- July 2024
- 157 Pages
Global
From €2195EUR$2,500USD£1,883GBP
- Report
- May 2025
- 175 Pages
Global
From €3941EUR$4,490USD£3,382GBP
- Report
- April 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,382GBP
- Report
- February 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,382GBP
- Report
- February 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,382GBP
- Report
- January 2025
- 175 Pages
Global
From €3941EUR$4,490USD£3,382GBP
- Report
- July 2025
- 374 Pages
Global
From €5135EUR$5,850USD£4,407GBP
- Report
- July 2025
- 202 Pages
Global
From €5135EUR$5,850USD£4,407GBP
- Report
- June 2025
- 400 Pages
Global
From €4344EUR$4,949USD£3,728GBP
- Report
- June 2025
- 400 Pages
Global
From €4344EUR$4,949USD£3,728GBP
- Report
- June 2025
- 400 Pages
Global
From €4344EUR$4,949USD£3,728GBP
- Report
- June 2025
- 400 Pages
Global
From €4344EUR$4,949USD£3,728GBP
- Report
- January 2025
- 250 Pages
Global
From €4388EUR$4,999USD£3,766GBP
- Report
- July 2024
- 200 Pages
Global
From €4344EUR$4,949USD£3,728GBP
- Report
- June 2025
- 400 Pages
Global
From €4344EUR$4,949USD£3,728GBP
- Report
- June 2025
- 400 Pages
Global
From €4344EUR$4,949USD£3,728GBP

The AIDS market within the context of Allergy and Immunology is focused on the development of treatments and therapies for HIV/AIDS. This includes the development of drugs to treat HIV infection, as well as vaccines and other therapies to prevent the spread of the virus. Additionally, research is being conducted to better understand the mechanisms of HIV infection and the development of new treatments.
The market is highly competitive, with many companies vying for a share of the market. Companies such as Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and ViiV Healthcare are all major players in the AIDS market. Other companies such as AbbVie, Janssen, and Pfizer are also involved in the development of treatments and therapies for HIV/AIDS. Show Less Read more